Study for the treatment of multiple sclerosis

Are you

• a healthy fertile woman who uses oral contraception or is willing to take the oral contraception provided by us for the study
• between 18 and 45 years (inclusive)
• with a BMI between 18.0 and 30.0 kg/m² (inclusive)
  • with a minimum body weight of 50.0 kg
• who does not smoke or has stopped smoking at least 3 months before screening
  • nicotine-containing products (e.g., nicotine patches) must be discontinued at least 3 months prior to screening
• and does not use daily medication other than contraception

What does this study involve?

In study 2500394, SGS is investigating the treatment of multiple sclerosis. The study lasts approximately 18 weeks, with the following contact moments:

• a screening visit
• a stay of:
  • Cycle 2: 3 days (2 nights)
  • Cycle 3: 11 days (10 nights)
• 2 morning return visits
• an end of trial visit

Take part in this trial and

• contribute to the medicine of tomorrow
• a compensation will be provided

This study was approved by the competent Belgian health authorities and an independent ethics committee.

View information leaflet cohort 5

View study dates cohort 5